F Star Therapeutics Inc (FSTX) Return on Investment ROI from the third quarter of 2022 to third quarter of 2021 and for the year 2022, average high and low, overall ranking from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
F star Therapeutics Inc   (NASDAQ: FSTX)


F Star Therapeutics Inc's ROI from its third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is F Star Therapeutics Inc's ROI in the third quarter of 2022?
F Star Therapeutics Inc recorded a cumulative net loss of $-44 million during 12 months ending in the third quarter of 2022, resulting in a negative return on investment (ROI) of -48.42%.

Within the Healthcare sector 660 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2022 from 4567 to 4645.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Investment Change TTM 19.75 % 104.63 % 431.89 % 685.08 % 812.12 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 69 85 102 111 106
Return On Investment (TTM) -48.42 % -36.46 % -30.88 % -33.73 % -54.57 %
FSTX's Overall Ranking # 4645 # 4567 # 4529 # 4814 # 4346
Seq. Investment Change TTM -9.13 % -6.84 % 16.96 % 20.95 % 55.27 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -44 -37 -34 -31 -42

FSTX Company Profile >> Back to FSTX Roi Comparisons >> See Annual FSTX Return On Investment



Return On Investment FSTX's Ranking
Within: No.
Industry # 283
Sector # 661
Overall # 4645

Return On Investment Statistics
High Average Low
-30.1 %
-77.95 %
-292.47 %
(Mar 31 2022)   (Sep 30 2020)







Financial Statements
F Star Therapeutics Inc's III. Quarter Investments $ 69 Millions FSTX's Balance sheet
F Star Therapeutics Inc's III. Quarter Income $ -18 Millions Quarterly FSTX's Income Statement
FSTX's Income by Division See FSTX's Income by Division


FSTX Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Investments in Millions 111 47 58 65 48
Y / Y Investment Growth 137.79 % -19.31 % -10.49 % 34.77 % 104.92 %
Net Income in Millions -31 -26 -24 -23 -28
Y / Y Net Income Growth - - - - -
Annual Return On Investment -28.21 % -54.94 % -41.7 % -35.4 % -57.78 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
FSTX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for FSTX's Competitors
Subscribers only: Roi for F Star Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for FSTX's Customers

Other Ratios
FSTX's Roa FSTX's Inventory Turnover Ratio FSTX's Growth Rates FSTX's Dividend Statistics
FSTX's Profitability Ratios FSTX's Asset Turnover Ratio FSTX's Dividend Growth
FSTX's Roe FSTX's Valuation Ratios FSTX's Financial Strength Ratios FSTX's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2022, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.